Treatment of leukemia patients with T101 ricin A chain immunotoxins.
Laurent
G
G
Frankel
A E
AE
Hertler
A A
AA
Schlossman
D M
DM
Casellas
P
P
Jansen
F K
FK
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D000943:Antigens, Differentiation / Q000276:immunology*; D018956:CD5 Antigens; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009360:Neoplastic Cells, Circulating; D012276:Ricin / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D000943:Antigens, Differentiation; D018956:CD5 Antigens; D000922:Immunotoxins; D012276:Ricin